Muhajiran, Abdul Nakir B.
HRN: 22-28-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/03/2022
12/10/2022
IV
60mg
Q12hours
Aspiration Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes